The Wales Cancer Research Centre: improving cancer care together

por Chester, John D, Bond, Jodie R, Batt, Elisabeth A
Publicado 2017

Histone deacetylase inhibitor trichostatin A sensitises cisplatin-resistant ovarian cancer cells to oncolytic adenovirus

por Hulin-Curtis, Sarah L., Davies, James A., Jones, Rachel, Hudson, Emma, Hanna, Louise, Chester, John D., Parker, Alan L.
Publicado 2018

Pseudotyped αvβ6 integrin-targeted adenovirus vectors for ovarian cancer therapies

por Uusi-Kerttula, Hanni, Davies, James, Coughlan, Lynda, Hulin-Curtis, Sarah, Jones, Rachel, Hanna, Louise, Chester, John D., Parker, Alan L.
Publicado 2016

Incorporation of Peptides Targeting EGFR and FGFR1 into the Adenoviral Fiber Knob Domain and Their Evaluation as Targeted Cancer Therapies

por Uusi-Kerttula, Hanni, Legut, Mateusz, Davies, James, Jones, Rachel, Hudson, Emma, Hanna, Louise, Stanton, Richard J., Chester, John D., Parker, Alan L.
Publicado 2015

Identification of folate receptor α (FRα) binding oligopeptides and their evaluation for targeted virotherapy applications

por Hulin-Curtis, Sarah L., Davies, James A., Nestić, Davor, Bates, Emily A., Baker, Alexander T., Cunliffe, Tabitha G., Majhen, Dragomira, Chester, John D., Parker, Alan L.
Publicado 2020

Efficient Intravenous Tumor Targeting Using the αvβ6 Integrin-Selective Precision Virotherapy Ad5(NULL)-A20

por Davies, James A., Marlow, Gareth, Uusi-Kerttula, Hanni K., Seaton, Gillian, Piggott, Luke, Badder, Luned M., Clarkson, Richard W. E., Chester, John D., Parker, Alan L.
Publicado 2021

Development of a low-seroprevalence, αvβ6 integrin-selective virotherapy based on human adenovirus type 10

por Bates, Emily A., Davies, James A., Váňová, Jana, Nestić, Davor, Meniel, Valerie S., Koushyar, Sarah, Cunliffe, Tabitha G., Mundy, Rosie M., Moses, Elise, Uusi-Kerttula, Hanni K., Baker, Alexander T., Cole, David K., Majhen, Dragomira, Rizkallah, Pierre J., Phesse, Toby, Chester, John D., Parker, Alan L.
Publicado 2022